13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE Filed 2025-03-10 Event 2025-02-18 SEC 0000921895-25-000727 →

Lazar David E. FiEE, Inc. FIEE

Stake: 35.10% Shares: 2,802,254 CUSIP: 60365W102 Class: Common Stock, $0.01 par value

Item 4 — Purpose of Transaction

Item 4 is hereby amended to add the following: The February Purchase Agreement (as defined in Item 6 below) contains customary representations, warranties and agreements of the parties, as well as certain limitations and conditions, indemnification rights and other obligations. The February Purchase Agreement contains certain covenants that the parties are obligated to comply with, such as the Reporting Person providing satisfactory evidence to the Purchasers that: (i) each consulting or other agreement between the Issuer and each of Matthew McMurdo and ABZ Law Office have been terminated; (ii) each of Avraham Ben-Tzvi, Andrew Papanicolau, Matthew McMurdo, Patrick Rivard, and David Natan has resigned as a director of the Issuer; and (iii) the Board of Directors of the Issuer has approved decreasing the size of the Board of Directors to three directors.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
21 13D/G filings on this issuer
20 other filings besides this one
Filer Track Record
6 filings by this filer
5 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 2.34
10,310 shares short · -5.5% vs prior

Post-Filing Returns · since 2025-02-18 on FIEE

+1 day
-5.5%
+5 days
-14.5%
+30 days
-14.5%
+60 days
+67.3%
+90 days
+272.7%
+180 days
+421.8%

Anchor price 0.55 on closest trading day on/after 2025-02-18. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on FiEE, Inc.

FiledFormFilerStakeShares
2026-05-22 SCHEDULE 13D/A Cao Yu 40.60% 4,615,012 view →
2026-01-08 SCHEDULE Yu Cao 42.10% 4,615,012 view →
2025-01-15 SCHEDULE HITCHCOCK JEREMY P. view →
2024-01-02 SC HITCHCOCK JEREMY P. view →
2023-12-11 SC HITCHCOCK JEREMY P. view →
2023-10-11 SC HITCHCOCK JEREMY P. view →
2023-03-14 SC HITCHCOCK JEREMY P. view →
2021-08-20 SC HITCHCOCK JEREMY P. view →
2021-08-02 SC Palm Management (US) LLC view →
2020-12-08 SC HITCHCOCK JEREMY P. view →
2020-11-16 SC HITCHCOCK JEREMY P. view →
2020-10-14 SC MANNING FRANK BLASE view →
2020-10-13 SC HITCHCOCK JEREMY P. view →
2020-09-30 SC HITCHCOCK JEREMY P. view →
2020-09-04 SC HITCHCOCK JEREMY P. view →
2020-08-04 SC HITCHCOCK JEREMY P. view →
2020-04-08 SC HITCHCOCK JEREMY P. view →
2020-01-21 SC HITCHCOCK JEREMY P. view →
2020-01-15 SC HITCHCOCK JEREMY P. view →
2019-10-21 SC HITCHCOCK JEREMY P. view →

Other Filings by Lazar David E.

FiledFormIssuerStakeShares
2026-07-02 SCHEDULE 13D/A KALA BIO, Inc. KALA 3.90% 719,404 view →
2026-04-28 SCHEDULE 13D MAINZ BIOMED N.V. QUCY 97.40% 477,000,000 view →
2026-01-29 SCHEDULE NovaBay Pharmaceuticals, Inc. SDEV 4.99% 6,388,000 view →
2024-04-08 SC OPGEN INC CFOR view →
2022-07-11 SC EQUUS TOTAL RETURN, INC. EQS view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →